Skyrizi (Risankizumab) 150mg/mL Prefilled Syringe

$20,750.00

Plaque Psoriasis
– 150 mg SC at Week 0, Week 4

THEN,
– 150 mg SC every 12 weeks thereafter

Psoriatic Arthritis
– 150 mg SC at Week 0, Week 4
THEN,
– 150 mg SC every 12 weeks thereafter
– May be administered alone or in combination with nonbiologic disease-modifying antirheumatic drugs (DMARDs)
Crohn Disease
– 600 mg IV at Week 0, Week 4, Week 8
THEN,
– 360mg SC on 12 week
THEN,
– 360 mg SC every 8 Weeks thereafter
Find a Physician:
NDC: 00074-1050-01 Categories: ,

1 Syringe = 1 Unit

Description

Administration
– SC administration only
– Discard prefilled syringes after use; do not reuse
Self-Injections
– Administer injections at different anatomic locations (eg, thighs, abdomen), and avoid areas where skin is tender, bruised, erythematous, indurated, or affected by psoriasis
– Administration in the upper, outer arm may only be performed by a healthcare professional or caregiver
– Drug is intended for use under the guidance and supervision of a healthcare professional, who may train patient and caregivers to self-inject using the subcutaneous injection technique
Missed Dose
– If a dose is missed, administer dose as soon as possible
– Resume dosing at the regular scheduled time
Dosing Considerations
– Evaluate for tuberculosis (TB) before initiating treatment
 
Storage
– Refrigerate at 2-8°C (36-46°F)
– Do not freeze; do not shake
– Keep prefilled syringes in the outer carton to protect from light
– Not made from natural rubber latex